NCT03750175View on ClinicalTrials.gov

OPTImal PALliative Anti-epidermal Growth Factor Receptor Treatment in Metastatic Colorectal Cancer -

CompletedOBSERVATIONAL
Enrollment

49

Participants

Timeline

Start Date

June 1, 2018

Primary Completion Date

June 1, 2022

Study Completion Date

December 31, 2022

Conditions
Colorectal Cancer MetastaticCirculating Tumor DNAKRAS Gene MutationNRAS Gene MutationBRAF Gene MutationEpidermal Growth Factor Receptor Inhibitor
Interventions
OTHER

Plasma circulating DNA analysis

Clinical utility of ctDNA analysis for treatment decision

Trial Locations (1)

8000

Aarhus University Hospital, Aarhus

All Listed Sponsors
lead

Karen-Lise Garm Spindler

OTHER

NCT03750175 - OPTImal PALliative Anti-epidermal Growth Factor Receptor Treatment in Metastatic Colorectal Cancer - | Biotech Hunter | Biotech Hunter